I am a clinical hepatologist with a special expertise in non-alcoholic fatty liver disease (NAFLD).
My research interests in the field of NAFLD are mainly focused on elastography (Fibroscan) and biochemical biomarkers, with the ultimate goal of targeting liver biopsy to patients at high risk of having steatohepatitis and fibrosis.
I am also interested in the pathophysiological mechanisms, the natural history of NAFLD, as well as novel therapeutic targets.